108results about How to "Solution stable" patented technology

A tamper evident closure (1) includes a housing (5) containing a blister pack (2) and a substrate (3), wherein the blister pack (2) contains a first reagent which is visible prior to first opening and the substrate (3) contains a second reagent. First opening of the closure ruptures the blister pack thereby exposing the first reagent to the second reagent and effecting a reaction that causes a visual change that signals the closure has been opened. The tamper evident closure of the present invention is primarily intended to be used as an anti-counterfeit measure on a spirit or pharmaceutical bottle. In the preferred embodiment, the closure incorporates a liquid that when brought into contact with a reagent chemical contained in an absorbent pad, effects an irreversible color change. This color change will indicate to a consumer the bottle has been previously opened or tampered with. The design makes it very difficult for a counterfeiter to cover up or eradicate the visible effects. In particular, the only way a counterfeiter could do this would be to put in a replacement blister and an absorbent pad. Filling a blister pack with a liquid is a highly specialist task which makes replication very difficult. The ability to control the color change to complement the branded goods provides a way of building up consumer recognition of the product and thereby establishing confidence in those products that carry the tamper evident closure of the present invention.

A novel pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound and its pharmaceutically acceptable salt has a potent FAAH-inhibitory activity. Further, the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound of the present disclosure is also useful in the treatment of urinary frequency and urinary incontinence, overactive bladder and / or pain.

A substrate treating apparatus for performing a predetermined treatment of substrates, includes a treating tank for storing a treating solution, a holding mechanism for holding the substrates, and loading and unloading the substrates into / from the treating tank, a first lid member for opening and closing an upper opening of the treating tank, the first lid member having an insert opening for receiving a back plate of the holding mechanism, and a second lid member disposed on the first lid member for opening and closing the insert opening. When the holding mechanism is outside the treating tank and the first lid member is closed, the second lid member closes an area above the insert opening, and forms lateral openings.

A curable composition comprises (a) at least one polyorganosiloxane, fluorinated polyorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydroxysilyl moieties; (b) at least one polyorganosiloxane, fluorinated polyorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydrosilyl moieties; and (c) a catalyst composition comprising (1) at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof, and (2) at least one Lewis acid; wherein at least one of the components (a) and (b) has an average reactive silane functionality of at least three.